02.24.26 -- January 2026 — CDMO Opportunities And Threats Report

A thorough and adaptable analytical strategy is essential for navigating the complex mAb market. This approach boosts the likelihood of market approval and unlocks the full potential of these therapies.

Embrace the transformative power of predictive modeling and digital twin technology to optimize bioprocess efficiency, ensure product quality, and drive innovation in biopharmaceutical manufacturing.

Successfully mitigate geopolitical risk and maintain supply continuity. Learn how a large-scale manufacturing process was rapidly requalified in eight months to secure a clinical-stage biologic program.

Enable scalable, high-yield AAV manufacturing with minimal contamination that delivers >10¹⁷ genome copies per 200L run and supports efficient, GMP-compliant production for diverse serotypes.

Outlined here are the benefits of PFS and how they relate to drug delivery, how SARS-CoV-2 could be fueling an explosive increase in demand, and how a partnership with a flexible CDMO is the key.

One main mRNA technology challenge is the formulation of delivery systems like LNPs. Learn about evading impurities in lipids, the future of mRNA-based genomic medicines, and more.

Explore how adaptable technologies and strategic partnerships help navigate Annex 1 compliance and technical hurdles to ensure the successful delivery of complex drug products.

Uncover why leveraging strong scientific expertise and comprehensive testing techniques will be vital in expediting development and upholding the integrity of these life-saving treatments.

Delve into how cloud-based systems and unified data platforms are transforming biomanufacturing by enhancing efficiency, ensuring quality, and accelerating the delivery of complex therapies to market.

Gain insight into an integrated drug substance/drug product offering for your IND program and beyond, with a holistic approach to ensure process robustness at every stage.

Discover how to mitigate risks in global pharmaceutical manufacturing by learning from Joon Chang and Tracey Partington’s decades of industry experience.

Operational excellence meets ethical stewardship. Data-driven strategies and renewable energy integration are shaping a responsible future for global manufacturing and community engagement.